Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanolytics is a specialized Contract Research Organization (CRO) based in Germany that focuses on the biophysical characterization of nanoparticles and macromolecules. The company is a global leader in Analytical Ultracentrifugation (AUC), providing high-resolution analysis for the pharmaceutical and biotechnology industries. Their services include the study of protein aggregation, viral vector purity, and the characterization of liposomes and other drug delivery systems. Nanolytics is particularly recognized for its expertise in Adeno-Associated Virus (AAV) analysis, specifically in determining empty/full capsid ratios. In addition to contract research, the company develops specialized instrumentation and software to enhance analytical precision in complex biological matrices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanolytics.